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AbsTrACT
background and purpose Stroke in young individuals 
is a serious public health burden. This study aimed to 
characterise the various phenotypes of ischaemic stroke 
in a young urban population (≤50 years old) using the 
ASCOD classification system, which assigns a score to five 
stroke categories: atherosclerosis, small vessel disease 
(SVD), cardioembolism, other and dissection. Within each 
category, a numerical score represents the degree of 
causality attributed to the stroke.
Methods This retrospective study cohort was composed 
of patients from an urban tertiary care academic centre. 
Cases were selected by searching Get With the Guidelines 
database for adults ≤50 years old with ischaemic stroke. 
The study sample included 175 ischaemic strokes in 157 
patients, with 16 subjects re-infarcting. Using retrospective 
chart review, each stroke was scored according to the 
ASCOD classification system. Multivariable logistic 
regression analyses were performed to explore each 
ASCOD category’s association with causal risk factors.
results Of possible causal mechanisms, defined as 
receiving a grade 1 or 2, a cardiovascular aetiology was most 
prevalent (25.7%), followed by SVD (22.3%), and closely by 
atherosclerosis (21.1%). Of general phenotypes, defined as 
receiving a grade 1 or 2 or 3, atherosclerosis was the most 
prevalent (51.4%), followed by SVD (47.4%), cardioembolism 
(42.3%) and other (35.4%). 31.6% of all strokes were of 
unclear aetiology. Subjects between 45 and 50 years old 
were more likely to develop a cardioembolic or SVD stroke 
when compared with subjects <45 years old.
Conclusion This study took a novel approach to ASCOD 
phenotyping, allowing several observations: (1) In patients 
with advanced atherosclerosis receiving the score A1, 
the vast majority had systemic atherosclerosis in multiple 
vascular territories; (2) the cardiac score C2(6), defined as a 
radiographic pattern highly suggestive of a central embolic 
source, may overestimate the prevalence of true cardiac 
disease; (3) incidental laboratory findings may detect some 
underlying pathology, but causality to the stroke is unlikely.
InTroduCTIon
While stroke is predominantly a disease of the 
elderly, in the past decade, ischaemic stroke 
has disproportionately affected young adults. 
There is an increasing rate of stroke in young 
people under 55 years old, which is a serious 
public health burden. Studies indicate that 
post stroke, one-half of stroke in the young 
(SITY) patients do not return to work and have 
poor functional recovery.1 SITY patients have a 
longer time period for potential reinfarction; 
consequently, secondary prevention is crucial. 
However, it is unclear whether the aetiology 
of SITY is similar or different to stroke in the 
elderly. Currently, there is a lack of consensus 
guidelines on maximising secondary preven-
tion in young adults with stroke. A rigorous and 
comprehensive approach should investigate 
causal mechanisms underlying SITY for appro-
priate treatment, prognosis and secondary 
stroke prevention.
The following cohort was obtained from 
an academic urban tertiary care hospital that 
serves Northern Philadelphia, one of the 
poorest regions in the USA. Eighty-five per 
cent of patients are covered by government 
programmes, including 31% by Medicare and 
53% by Medicaid. In this cohort, young individ-
uals comprised 10.2% of all patients with isch-
aemic stroke in a 4-year period. The proportion 
of SITY from our study population is higher 
than that reported in other cohorts, such as 2% 
in L’Aquila, Italy,2 5% in a meta-analysis3 or 8% 
in Northern Manhattan.4 This may be explained 
be a high prevalence of vascular risk factors in 
Northern Philadelphia, including widespread 
hypertension and diabetes,5 increased rates of 
drug and alcohol abuse,6 and a predominantly 
African-American population.
This retrospective study aimed to charac-
terise the various phenotypes of ischaemic 
stroke in an economically disadvantaged popu-
lation, using the ASCOD classification system. 
Furthermore, the association between known 
risk factors (ie, age, hypertension, diabetes, etc) 
and specific ASCOD categories (atheroscle-
rosis, small vessel disease, etc) was investigated. 
Our purpose was a descriptive analysis of the 
stroke aetiologies and risk factors most preva-
lent in a young urban population.
MeThods
selection and description of participants
A total of 1924 cases of ischaemic stroke were 
retrospectively identified from an urban 
tertiary care centre by searching Get With 
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the Guidelines database from January 2011 to December 
2014. The following criteria were applied: (1) age ≥18 and 
≤50 at stroke onset; (2) discharge diagnosis of ischaemic 
stroke. Ischaemic stroke was defined as acute focal neuro-
logical deficits lasting >24 hours with brain imaging corre-
sponding to symptomatology.
A total of 175 ischaemic strokes met the inclusion 
criteria. Patients with repeat infarcts were counted more 
than once into the study. A repeat infarct was defined as 
a new vessel occlusion in a different vascular territory or 
new diffusion restriction. Enlarging infarcts or recrudes-
cence of previous strokes were not considered a repeat 
infarct.
MRI-negative strokes were defined as a persistent 
deficit without radiological evidence of infarction and 
were also included. Transient ischaemic attacks (TIAs) 
were excluded.
stroke evaluation
All patients were initially evaluated by a neurologist with 
a complete medical history and physical examination. 
Initial studies included brain CT and MRI, routine blood 
biochemistry and vascular studies of intracranial and 
extracranial arteries (magnetic resonance angiogram 
(MRA), computed tomography angiography (CTA), 
carotid duplex, transcranial Dopplers, angiography). 
Patients received a 12-lead ECG with a routine tran-
sthoracic echocardiogram; selective patients underwent 
transoesophageal echocardiogram. Cardioembolism was 
screened using ASCOD definitions of cardiac pathology, 
including ejection fraction <35%, atrial fibrillation >60 s, 
left atrial thrombus, endocarditis and so on. At the 
neurologist’s discretion, patients also received a hyper-
coagulability work-up (antithrombin III, factor V Leiden 
and prothrombin mutations, protein C and S deficien-
cies, antiphospholipid antibodies). If a high clinical suspi-
cion for cardiac source of embolism was present without 
evidence of structural heart disease, a loop recorder was 
placed.
The hospital electronic database was used to collect 
patient data, which included pertinent medical history, 
hospitalisations, laboratory studies and imaging studies. 
A vascular neurologist, senior neurology resident and 
medical student then scored each stroke using the 
ASCOD phenotyping. The team adjudicated ASCOD 
scoring as a consensus.
AsCod classification description
Previous methods of describing stroke aetiology focused 
on a single casual risk factor. The ASCOD phenotyping 
method describes all concurrent risk factors with varying 
degrees of causation. The ASCOD classification system 
represents five primary stroke aetiologies: atheroscle-
rosis, small vessel disease (SVD), cardioembolism, other 
and dissection.7 Within each aetiology, a numerical score 
represents the degree of causality attributed to the stroke. 
The scores are defined as 1, likely causal; 2, uncertain if 
causal; and 3, unlikely causal, but disease present. The 
score is determined by a combination of vascular imaging, 
brain imaging, cardiac studies, laboratory results and 
medical history. For instance, for atherosclerosis, A1 is 
carotid stenosis >50%, A2 is carotid stenosis between 30% 
and 50%, and A3 is the presence of atherosclerosis in any 
vascular territory. For more details on the specific criteria, 
please refer to the original paper ‘The ASCOD pheno-
typing of ischaemic stroke’ by Amarenco et al.
A score of 0 indicates no disease, and a score of 9 indi-
cates incomplete work-up. Each stroke receives a score in 
all five categories, for example, A1-S2-C0-03-D9 (athero-
sclerosis (likely causal), SVD (possibly causal), cardioem-
bolism (absent), other (absent), dissection (incomplete 
work-up)). Thus, ASCOD allows a detailed understanding 
of the unique stroke to each individual patient.
In this study, a novel approach was taken to ASCOD 
phenotyping. Typically, scorers adopt the higher grade, 
that is, A1+A3 would be considered A1. However, all 
grades present were included in this study. For example, 
a patient with severe atherosclerosis both ipsilateral (A1) 
and contralateral (A3) to the infarct, in addition to an 
aortic plaque (A2), would be considered A1+A2+A3, not 
only A1. The authors believed this would be a more inclu-
sive method to capture all abnormalities present, rather 
than just the more severe pathology.
statistical analysis
Data were expressed as frequencies and percentages for 
categorical variables and mean±SD (or range or quartile 
range) for continuous variables. Multivariable multino-
mial logistic regression analyses were performed on the 
ASCOD classifications to explore its association with other 
potential predictors or confounding variables. All the 
variables were entered into the model a priori without any 
specific selection, first by introducing age, sex, hyperten-
sion, smoking and diabetes, and second by adding blood 
lipids. However, none of the blood lipid variables showed 
significant predictive abilities for the ASCOD groups and 
hence were subsequently dropped. The adjusted ORs 
with their 95% CIs are reported in table 3. P values less 
than 0.05 were considered statistically significant. SAS 
V.9.3 (SAS Institute, Cary, North Carolina, USA) was used 
for all the data analyses.
resulTs
The study sample included 175 ischaemic strokes in 
157 patients. Sixteen subjects (10.2%) experienced one 
reinfarction, and 2 of those 16 had two reinfarctions. 
Patients ranged from 20 to 50 years old, with 58.6% men 
and 41.4% women. The cohort’s underlying risk factors 
are detailed in table 1: 65.0% had hypertension, 40.8% 
had diabetes, 33% had hyperlipidaemia and 61.8% were 
smokers.
AsCod distribution
Possibly causal phenotypes were defined as receiving grade 
1 or 2 (table 2). Of possibly causal phenotypes, a cardi-
ovascular aetiology was most prevalent (C1+C2=25.7%), 
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Table 1 Demographic data of young adults with ischaemic stroke
N Mean Median SD Q1 Q3 Minimum Maximum
Continuous variables
  Age 157 43.44 46.00 6.29 41.00 48.00 20.00 50.00
  NIHSS 151 5.51 4.00 5.35 2.00 7.00 0.00 26.00
  Homocysteine 150 10.68 9.75 4.64 7.90 12.00 3.30 38.20
  HbA1c 152 7.28 6.00 2.64 5.40 8.50 4.30 14.70
  T.Chol 155 182.57 172.00 57.09 150.00 202.00 92.00 415.00
  HDL 155 39.59 38.00 11.66 31.00 46.00 12.00 84.00
  TG 155 150.34 120.00 112.27 84.00 176.00 18.00 804.00
  LDL 151 110.98 107.00 41.55 86.00 129.00 35.00 303.00
Binary variables
  Gender, male 58.6% (92)
  Gender, female 41.4% (65)
  HTN 65% (102)
  Diabetes 40.8% (64)
  HLD 33.1% (52)
  Smoking 61.8% (97)
Binary variables expressed as % of total population (N).
HbA1C, glycated haemoglobin; HDL, high-density lipoprotein; HLD, hyperlipidaemia; HTN, hypertension;  LDL, low-density lipoprotein; 
N, number of subjects; NIHSS, National Institutes of Health Stroke Scale; Q1, first quartile; Q3, third quartile; T.Chol, total cholesterol; TG, 
triglyceride.
Table 2 Distribution of ischaemic strokes by ASCOD phenotype
1 2 3 0 9 1+2 1+2+3
Atherosclerosis 16.0% (28) 5.7% (10) 46.3% (81) 48.6% (85) 13.7% (24) 21.1% (37) 51.4% (91)
SVD 11.4% (20) 10.9% (19) 25.1% (44) 52.6% (92) 0.0% 22.3% (39) 47.4% (83)
Cardiac 12.0% (21) 14.3% (25) 22.3% (39) 54.8% (96) 2.9% (5) 25.7% (45) 42.3% (74)
Other 5.7% (10) 0.6% (1) 30.9% (54) 45.7% (80) 22.3% (39) 6.3% (11) 35.4% (62)
Dissection 1.7% (3) 0.0% 0.6% (1) 97.1% (170) 0.6% (1) 1.7% (3) 2.3% (4)
Data expressed as % of total population (N).
SVD, small vessel disease.
followed by SVD (S1+S2=22.3%), and closely by ather-
osclerosis (A1+A2=21.1%). Only 6.3% of strokes had a 
possible cause in the ‘other’ category. The least prevalent 
possibly causal phenotype was dissection at 1.7%.
Aside from grades 1 and 2, almost half of the popula-
tion scored A3 (46.3%), and almost a third scored O3 
(30.9%). One-fourth of strokes received S3; similarly, 
approximately one-fourth of strokes received C3. ‘Unclear 
aetiology’ was defined as a stroke lacking a grade of 1 or 
2, suggesting an undetermined causal mechanism. In this 
cohort, 31.6% of all strokes were of unclear aetiology.
General phenotypes were defined as receiving grade 1 
or 2 or 3. Of general phenotypes, atherosclerosis was the 
most prevalent (51.4%), followed by SVD (47.4%), cardi-
oembolism (42.3%) and other (35.4%). Dissection was 
the (2.3%) least common general phenotype.
Table 3 shows the possibly causal phenotypes that over-
lapped, defined as receiving grade 1 or 2 in two separate 
aetiologies. Moreover, 5.71% of strokes had both A and C 
and 3.43% of strokes had both S and C. ‘Other’ had no 
overlap with any other aetiology, and atherosclerosis and 
SVD had no overlap.
AsCod phenotype association with risk factors
Table 4 demonstrates whether specific risk factors were 
predictive of grade 1 ASCOD phenotypes. Two significant 
associations were discovered: subjects 45 and older were 
more likely to develop a C1 or S1 stroke when compared 
with subjects younger than 45. Gender, hypertension, 
diabetes or smoking did not predict the odds of an A1, 
S1, C1 or O1 stroke in this cohort. Additionally, no signif-
icant associations were found between risk factors and 
possibly causal ASCOD phenotypes (grades 1+2).
specific AsCod grade breakdown
Table 5 details the specific pathologies within each 
ASCOD grade. Of individuals receiving C1, there was one 
individual with endocarditis, two cases of atrial fibrillation, 
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Table 3 ASCOD phenotype overlap









Overlap between stroke phenotypes is demonstrated as % of all 
strokes.
Table 4 Multivariate adjusted associations of risk factors with phenotypes scoring a ‘1’ grade
Atherosclerosis (A1) SVD (S1) Cardioembolic (C1) Other (O1)
Female 2.50 (0.95 to 6.62) 0.85 (0.26 to 2.76) 1.12 (0.40 to 3.11) 1.78 (0.43 to 7.38)
p=0.065 p=0.785 p=0.834 p=0.427
Age 45–50 vs <45 1.58 (0.59 to 4.26) 4.15 (1.0716.13) 3.44 (1.12 to 10.62) 0.248 (0.051.30)
p=0.363 p=0.040* p=0.032* p=0.099
Hypertension 0.94 (0.32 to 2.79) 1.48 (0.39 to 5.70) 1.44 (0.45 to 4.66) 3.80 (0.6821.41)
p=0.910 p=0.568 p=0.539 p=0.130
Diabetes 1.06 (0.37 to 3.05) 1.16 (0.35 to 3.78) 0.89 (0.30 to 2.61) 0.46 (0.10 to 2.11)
p=0.913 p=0.809 p=0.828 p=0.318
Smoking 1.58 (0.55 to 4.54) 0.86 (0.28 to 2.68) 0.57 (0.21 to 1.54) 1.07 (0.26 to 4.44)
p=0.399 p=0.795 p=0.269 p=0.930
Values are expressed as OR (95% CI) with p value below.
Strokes not receiving a one grade were used as a reference category.
*Indicates a significant p value.
one heart transplant and the remaining individuals had 
an ejection fraction <35%. Of individuals who received 
a C2, the vast majority were C2(6), defined as ‘no direct 
cardiac source identified, but multiple brain infarction, 
repeated either bilateral or in two different arterial terri-
tories (…) and/or evidence of systemic emboli’.7
Of individuals receiving O1, three individuals had 
moyamoya, two individuals had systemic lupus and one 
individual had metastatic thyroid cancer compressing the 
vertebral artery. Of individuals who received an O3, 10 
had an elevated antiphospholipid antibody and 15 had 
elevated homocysteine. Moreover, 12.6% of all strokes 
had additional laboratories to suggest abnormal hyperco-
agulability, as specified in the Methods section.
dIsCussIon
This study took a novel approach to ASCOD phenotyping 
in a young, urban population by including all grades of 
causality within each aetiology, and within each grade, 
examining the stroke aetiologies in detail. The results 
yielded several patterns, depending on how ASCOD 
grades were combined. For possibly causal phenotypes, 
the most prevalent categories were cardioembolism, SVD 
and atherosclerosis, respectively. In contrast, for general 
phenotypes, the order of prevalence shifted to atheroscle-
rosis as the most common category, followed by SVD and 
cardioembolism.
Atherosclerosis as the most prevalent general pheno-
type may be attributed to the high percentage of A3 
(46.3%). Even in this young cohort, almost half of strokes 
showed at least a minimal level of atherosclerosis. Siri-
marco et al demonstrated that A3 conferred a similar risk 
profile as A1 in a 3-year follow-up study for reinfarction, 
non-fatal cardiac events and death from a vascular cause.8 
Those results illustrate the need for aggressive control 
of atherosclerosis, even at an early stage without clinical 
symptoms. Furthermore, in this cohort, nearly 80% of A1 
strokes had a concomitant A3 grade (12.6% of all strokes), 
suggesting that atherosclerosis is present at additional 
sites beyond the vessel supplying the infarct. Because this 
subset of patients with ischaemic stroke had systemic, 
rather than local, atherosclerosis, it was surprising to find 
a low overlap of atherosclerosis (A1/A2) with cardiac 
pathology (C1/C2). This result challenges the notion 
that intracranial and extracranial atherosclerosis share 
a similar pathophysiology to that of cardiac atheroscle-
rosis. Interestingly, while research supports using carotid 
intima–media thickness as a marker for future cardiac 
events,9 this association is not always as strong in black 
individuals, suggesting this surrogate marker may be 
racially dependent.10 11
Cardioembolism as the most prevalent possibly causal 
phenotype may be explained by 10.3% of all strokes 
receiving a C2(6). In the ASCOD criteria, C2(6) is 
defined as multiple brain infarcts in two vascular terri-
tories suggesting embolisms, with no identified cardiac 
pathology. This definition is comparable with embolic 
stroke of unknown source (ESUS).12 Key to the ESUS 
definition is an embolic origin that is not necessarily 
cardiac and also includes carotid/vertebral plaques, 
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Table 5 ASCOD grade breakdown
C1 Significant cardiac pathology and 
single infarct
Left ventricle EF <35%
7.4% (13) 2.3% (4)
C2 Left ventricle apical akinesia and 
decreased EF
No cardiac pathology but 
multiple infarcts
4.0% (7) 10.3% (18)
O1 Moyamoya disease Systemic lupus
2.9% (5) 2.3% (4)
O3 Abnormal hypercoagulability 
laboratories (see Methods)




12.6% (22) 8.6% (15) 5.7% (10) 2.9% (5)
Within each ASCOD grade, specific pathologies were quantified.
EF, ejection fraction.
aortic atheromas and rare variations of the circle of Willis. 
Consequently, the true incidence of cardioembolism as 
a causal mechanism may have been overestimated using 
the ASCOD classification scheme in this cohort. Similarly 
to the recommendations for cryptogenic stroke, addi-
tional high-quality trials should investigate whether the 
C2(6) patient subgroup would benefit from systemic anti-
coagulation or antiplatelet therapy.13
The authors were interested by the substantial number 
of O3 grades (30.9%), most of which were assigned due 
to incidental laboratory findings, such as an elevated 
homocysteine or positive antiphospholipid titre. Perhaps 
these findings were inflammatory markers resulting 
from the stroke or simply incidental laboratories. Wolf, 
a creator of the ASCOD phenotyping system, stated the 
aim of ASCOD was to best characterise the patient at 
the moment of the ischaemic stroke and document all 
abnormalities present.14 Whether these abnormalities are 
causal, incidental or a result of the stroke is left to the 
scorer’s discretion.
Multivariate logistic regression demonstrated that in 
this study population, subjects 45 and older were more 
likely to develop a cardioembolic or SVD stroke (C1 or 
S1) than subjects younger than 45. This suggests that 
the ‘young’ cohort may segregate into two extremes, 
the very young and the older young. A similar statistical 
model used by Jaffre et al found several more associations, 
including cardioembolism with age and also athero-
sclerosis with age, smoking, diabetes, hypertension and 
SVD with age and hypertension.15 Reasons why this study 
cohort failed to replicate Jaffre et al’s findings include a 
high baseline prevalence of hypertension, diabetes and 
smoking, masking the risk factors’ impact. Furthermore, 
this study’s variables were coded categorically rather than 
continuously; using the numerical values may have yielded 
a more sensitive detection of the various associations. In 
this cohort, the absence of the risk factor’s predictive 
value for stroke phenotype questions the use of stroke 
classification systems. However, as Elkind writes in a recent 
editorial, determining stroke aetiologies is valuable for 
prognostication.16 In a study comparing various scoring 
systems for stroke (ASCOD, TOAST, CCS), regardless 
of the classification system, cardioembolic strokes were 
associated with a decreased 90-day survival rate, a larger 
infarct area and a more severe deficit, as compared with 
other stroke aetiologies.17
Comparisons with other young cohorts reveal both 
similarities and differences. The sifap1 study (Stroke in 
Young Fabry Patients) found SVD (29.2%) and other 
(16.5%) as the most prevalent possibly causal mech-
anisms, although this study included TIAs and had a 
higher age cut-off of 55.18 In contrast, the Helsinki Young 
Stroke Registry revealed cardioembolism (19.6%) and 
dissection (15.4%) as the most common stroke mech-
anisms.19 The lower incidence of atherosclerosis in the 
Helsinki cohort can be explained by a healthier baseline 
population with lower incidence of obesity, hypertension, 
diabetes and smoking. A more analogous population to 
this study is the Northern Manhattan Study (NOMAS), 
with multiple vascular risk factors and a high incidence 
of African Americans and Hispanics. The findings of this 
study were in line with NOMAS, which also had high 
levels of undetermined aetiology and a low incidence of 
cardioembolic strokes.4
This study had several limitations, including the high 
percentage of incomplete work-up, which was attributed 
to the rigorous application of ASCOD criteria for the 9 
grade. Furthermore, this cohort had risk factors unique to 
a low socioeconomic area, so the results may not be gener-
alisable to other regions. Other characteristics impacting 
stroke risk that merit further investigation include drug 
and alcohol abuse, nutrition and environmental stressors. 
Additionally, this statistical analysis included repeat 
strokes (up to three strokes in one patient), which may 
have over-represented aetiologies in recurrent strokes 
such as untreated atrial fibrillation or moyamoya disease.
In summary, this study used the ASCOD phenotyping 
system to describe aetiologies and their level of causality 
to ischaemic stroke in individuals <50 years old. In this 
urban cohort, the findings emphasise cardioembolism 
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as the leading possibly causal mechanism and athero-
sclerosis as the leading general phenotype. As we have 
attempted to demonstrate, the significance and impli-
cations of a stroke classification system are not limited 
to its original definition. Ultimately, ASCOD scoring is 
a dynamic process and can be applied to an individual 
stroke to personalise secondary prevention and analysed 
on a population level to detect patterns of risk factors.
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